Indegene Inks Deal for CultHealth

Indegene, a technology-led healthcare solutions company, has purchased CultHealth, a full-service, healthcare marketing agency for various life sciences brands. The acquisition by ILSL Inc., a subsidiary of Indegene Private Limited, strengthens Indegene’s commercialization portfolio spanning drug discovery and development to marketing and sales, adding brand strategy and market development capabilities along with patient engagement platforms.

The agency has experience in medical strategy, creative, and omnichannel planning services. It engages with life sciences companies at a medical/academic level, providing insight on drug mechanism of action (MOA) and customer behavior to develop insights for brand campaigns and creatives.

“With CultHealth, our life sciences clients benefit from partnering with a single service provider, all the way from brand strategy through commercialization. The CultHealth team brings nuanced expertise in reaching patients and physicians with meaningful DTC and marketing efforts, with a special emphasis on therapeutic areas of diabetes and oncology,” comments Manish Gupta, Indegene Private Limited’s executive director and CEO. “Their long-standing relationships with some of the large, global life sciences companies and a record of growing business speaks volumes about the unique talent and culture nurtured at CultHealth.”